Sun Pharma and Taro Reach Definitive Merger Agreement

Estimated read time 1 min read

Sun Pharmaceutical Industries will purchase Taro’s outstanding shares for $43 each, which will total $348 million.

You May Also Like

More From Author

+ There are no comments

Add yours